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Differential and Workup
Myasthenia Gravis
• CT Chest: no mediastinal/thymic mass (thymoma)
• Acetylcholine Receptor Ab: negative
• Striated Muscle and Titin Ab: negative
Lambert Eaton
• Pre-synaptic defect on EMG: low motor amplitudes 
that increased with sustained exercise
• Voltage Gated Calcium Chanel Ab: negative
• CT Chest: no nodules or masses (paraneoplastic SCLC 
in 50%)
Demyelinating Polyneuropathy
• LP: Glucose 76, protein 53, WBC 0, RBC 0, 
lymphocytes 67%
• CSF: Ganglioside GM1 Ab negative
Botulism
• Stool: rejected, poor specimen quality
• Serum: small sample size, Endopep-MS assay 
negative
Central and Infectious
• MRI brain and C-spine normal
Infectious
• Treponemal Ab negative
• Lyme Ab negative
Accidental Botulism Poisoning: A Case of Pickled Herring
Garrett Spencer, MD, Greg Flick, MD
Providence St. Vincent, Internal Medicine Residency, Portland, Oregon
Botulism is a rare cause of neuromuscular weakness that 
presents a diagnostic challenge in the face of respiratory 
collapse.
Pupil and bulbar paralysis aid prompt recognition and 
treatment, as clinical confirmation can be time intensive and 
limited by sample integrity. Early treatment can halt paralysis 
and prevent ICU and ventilator days.
INTRODUCTION
A 74-year-old male with hypertension and DVT presented with 
acute weakness and respiratory failure after three days of 
cough and diarrhea. Upon ICU admission for mechanical 
ventilation, we discovered sluggish pupils, mild ptosis, and 
proximal muscle weakness. Symptoms then progressed to 
unresponsive pupils, complete ptosis, and complete paralysis.
While we suspected a neuromuscular cause, no single cause 
was identified despite extensive workup and neurology 
consultation. Our differential was narrowed after 
electromyogram (EMG) demonstrated a pre-synaptic defect, 
indicating either Lambert Eaton or Botulism as culprits. 
Empiric treatment with botulism anti-toxin resulted in clinical 
improvement of ptosis and proximal weakness.
While ventilated, he wrote of recent pickeled herring ingestion, 
possibly left unrefrigerated for a week. He ultimately received 
tracheostomy and transfer to long-term assisted care, and at 
discharge stool and serum testing for botulism toxin was still 
pending. While state-run testing finally returned negative, his 
illness was ultimately attributed to accidental botulism 
poisoning.
CASE DESCRIPTION
Yearly US incidence of botulism is 100 cases, and early treatment with equine anti-toxin reduces 
mortality and ventilation time1. Timely diagnosis is challenging as respiratory collapse 
overshadows subtle pupil and bulbar paralysis unique to botulism2. 
Lab diagnosis with Endopep-MS assay is not FDA approved and can be falsely negative with 
small samples3 while verified sacrificial mouse bioassays are rarely used2. Early suspicion 
should prompt anti-toxin treatment and discussion with the CDC’s botulism consultation 
service, who will supply anti-toxin and provide assistance with workup in conjunction with 
state health laboratories.
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Botulism Key Features
Exam
• Respiratory collapse
• Proximal then distal paralysis, rapid progression
• Preserved sensation, reflexes
• Bulbar Paralysis with pupil involvement, nystagmus
Workup
• Botulism Neurotoxin (BoNT) of fluid, serum samples
• Mouse Bioassay
Treatment
• Botulism equine anti-toxin, early administration can 
reduce ventilator and ICU days
Sacrificial Mouse Bioassay
BoNT Present
BoNT Absent
Sample suspected for Botulism Neurotoxin (BoNT) 
injected in peritoneum of mouse, compared to 
control. After 3-5 days incubation, presence of 
BoNT confirmed by rapid paralysis and death of 
mouse.
